[1]
Mohamad, A.F. et al. 2022. MACROPROLACTINEMIA WITH CO-EXISTING PITUITARY MACROADENOMA AS A DIFFERENTIAL FOR DOPAMINE-AGONIST RESISTANT PROLACTINOMA. Journal of the ASEAN Federation of Endocrine Societies. 37, (Jul. 2022), 38. DOI:https://doi.org/10.15605/jafes.037.S2.34.